DAFALGAN Direct cpr orodisp 500 mg bte 16 pce
7680551380016
CH-55138
N02BE01
01.01.1.
1 / 2
google
Details
- Product number
- 5513802
- CPT
- -
- Packaging group
- 16
- Unit
- Tablette(n)
- Composition
- paracetamolum 500 mg, ethylcellulosum, acidum citricum, natrii hydrogenocarbonas, sorbitolum 30.5 mg, natrii carbonas, saccharum 105.83 - 109.17 mg, maltodextrinum et glucosum 2.23 - 5.57 mg et crospovidonum, E 211 25 mg, aspartamum 4.8 mg et acesulfamum kalicum, aromatica, pro compresso corresp. natrium 39 mg.
Articles (1)
Dafalgan Direct, Schmelztabletten
Schmelztabletten
16
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
500.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
30.5 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
25.0 MG | Substance | HBESI |
|
(N/A)
|
4.8 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
39.0 MG | Substance | HBESI |
Authorization holder
UPSA Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 55138
- Drug name
- Dafalgan Direct, Schmelztabletten
- Galenic form
- SCHM
- ATC Code
- N02BE01
- Authorization status
- Z
- Dispensation category
- D
- First authorization
- 27/02/2002
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAFALGAN Direct cpr orodisp 500 mg bte 16 pce
- Description (DE)
- DAFALGAN Direct Schmelztabl 500 mg Ds 16 Stk
- Market launch
- 18/10/2013
- Narcotic (BTM)
- No